Search research articles
Contact Us
Filters
Showing results (261-270 of 527) with videos related to
Page
of 53
Sort By:
Journal of Gastroenterology and Hepatology
|
April 9, 2013
Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin
Chung-Feng Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, et al.
Plos One
|
May 13, 2022
Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patients
Batbold Batsaikhan, Ching-I Huang, Ming-Lun Yeh, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
December 19, 2012
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
Chung-Feng Huang, Ming-Lung Yu, Jia-Horng Kao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 19, 2017
More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma
Tomi W Jun, Ming-Lun Yeh, Ju Dong Yang, et al.
Medicine
|
March 9, 2018
Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes
Ching-I Huang, Chung-Feng Huang, Ming-Lun Yeh, et al.
Plos One
|
March 26, 2013
Virological predictors of response to retreatment in hepatitis C genotype 2 infected patients
Chung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, et al.
Journal of Hepatology
|
June 28, 2011
Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin
Chung-Feng Huang, Jee-Fu Huang, Jeng-Fu Yang, et al.
Alimentary Pharmacology & Therapeutics
|
October 27, 2018
Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan
Chen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
March 25, 2023
High-Resolution Genomic Profiling of Liver Cancer Links Etiology With Mutation and Epigenetic Signatures
Shira Perez, Anat Lavi-Itzkovitz, Moriah Gidoni, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 3, 2025
Limited use of FIB-4 index in patients under 65 years of age with type 2 diabetes mellitus
Mimi Kim, Eileen L Yoon, Huiyul Park, et al.
Page
of 53
Search research articles
Search
Showing results (261-270 of 527) with videos related to
Sort By:
Page
of 53
Journal of Gastroenterology and Hepatology
|
April 9, 2013
Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin
Chung-Feng Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, et al.
Plos One
|
May 13, 2022
Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patients
Batbold Batsaikhan, Ching-I Huang, Ming-Lun Yeh, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
December 19, 2012
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
Chung-Feng Huang, Ming-Lung Yu, Jia-Horng Kao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 19, 2017
More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma
Tomi W Jun, Ming-Lun Yeh, Ju Dong Yang, et al.
Medicine
|
March 9, 2018
Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes
Ching-I Huang, Chung-Feng Huang, Ming-Lun Yeh, et al.
Plos One
|
March 26, 2013
Virological predictors of response to retreatment in hepatitis C genotype 2 infected patients
Chung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, et al.
Journal of Hepatology
|
June 28, 2011
Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin
Chung-Feng Huang, Jee-Fu Huang, Jeng-Fu Yang, et al.
Alimentary Pharmacology & Therapeutics
|
October 27, 2018
Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan
Chen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
March 25, 2023
High-Resolution Genomic Profiling of Liver Cancer Links Etiology With Mutation and Epigenetic Signatures
Shira Perez, Anat Lavi-Itzkovitz, Moriah Gidoni, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 3, 2025
Limited use of FIB-4 index in patients under 65 years of age with type 2 diabetes mellitus
Mimi Kim, Eileen L Yoon, Huiyul Park, et al.
Page
of 53